Y-mAbs Therapeutics
YMAB
#8266
Rank
C$0.25 B
Marketcap
$5.57
Share price
-2.66%
Change (1 day)
-73.41%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -C$42.86 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are C$87.68 Million. a decrease over its 2023 earnings that were of -C$35.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -C$43.24 Million21.54%
2023 -C$35.58 Million-72.92%
2022 -C$0.14 Billion77.47%
2021 -C$74.04 Million-55.46%
2020 -C$0.17 Billion44.49%
2019 -C$0.12 Billion92.01%
2018 -C$59.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion 357.98%๐Ÿ‡บ๐Ÿ‡ธ USA